Inflammatory cytokines and antigen presenting cell activation.

Area of Science:

• Immunology
• Veterinary Medicine
• Vaccinology

Background:

• Animal immune systems require rapid responses to pathogens and sustained immunity to prevent reinfection.
• Inflammatory cytokines, produced by macrophages and antigen-presenting cells (APCs), are key mediators of these dual immune needs.
• Mucosal surfaces are primary infection sites, posing challenges for inducing protective immunity.

Purpose of the Study:

• To review the role of inflammatory cytokines in immune induction and APC function, focusing on swine and mucosal immunity.
• To explore how cholera toxin (CT) enhances mucosal immunity via APC activation.
• To establish the link between APC activation, cytokine expression, and vaccine adjuvant efficacy.

Main Methods:

• Literature review focusing on inflammatory cytokines, APCs, and mucosal immunity in animals, particularly swine.
• Analysis of the effects of cholera toxin (CT) on immune responses.
• Examination of the relationship between adjuvant function and inflammatory cytokine production.

Main Results:

• Inflammatory cytokines are essential for mobilizing the immune system and enhancing APC function.
• Cholera toxin (CT) potentiates cytokine and costimulatory molecule expression in macrophages, stimulating local and systemic immunity.
• APC activation, marked by inflammatory cytokine expression, is critical for antigen-specific immunity induction.

Conclusions:

• Activation of APCs is a central event in inducing antigen-specific immunity.
• Effective vaccine adjuvants likely function by inducing controlled inflammatory responses at mucosal sites.
• Elucidating cytokine patterns and APC activation is vital for rational vaccine design, particularly for mucosal immunity.